Adrenal infarction with latent myelodysplastic/myeloproliferative neoplasm, unclassifiable with JAK2V617F mutation

This report delves into the thrombogenicity linked to theJAK2V617F mutation, while also examining documented instances of adrenal infarction in myeloid neoplasms. We should consider evaluating forJAK2V617F mutation even in cases of thrombosis at unusual sites, including adrenal infarction, even if there are no considerable abnormalities in blood counts.
Source: Clinical Case Reports - Category: General Medicine Authors: Tags: CASE REPORT Source Type: research